A carregar...
Antithrombotic therapy in peripheral artery disease: A review of the EUCLID trial results and current ongoing trials
In addition to risk‐factor modification, antithrombotic therapy is the hallmark of management to reduce cardiovascular ischemic events in patients with peripheral artery disease (PAD). Currently, the guidelines recommend long‐term antiplatelet therapy with aspirin or clopidogrel in this patient popu...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6490002/ https://ncbi.nlm.nih.gov/pubmed/29355992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22839 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|